- Q3 Sales: $18.09B vs $17.31B estimate
- Adjusted EPS: $2.49 vs $2.07 estimate (GAAP EPS: $2.04 vs $1.86)
- Keytruda revenue at $8.60B beats $8.38B consensus; FY Gross Margin seen ~81%
?? Positive AI Sentiment (+6.5 / 10)
Observed market reaction after signal
4h +4.61% · Peak +5.91%